Undisclosed TIM-1 modulator / Larkspur Biosci - LARVOL DELTA

Larkspur Biosciences Announces First-in-Class Program Targeting Novel B Cell Checkpoint (GlobeNewswire) - "Larkspur Biosciences revealed today that one of their lead programs is a first-in-class B cell checkpoint, TIM-1. This announcement follows the publication...in the journal Nature of TIM-1 as a targetable checkpoint protein central to B-cell anti-tumor activity....Larkspur’s approach addresses the unique ways that tumors hijack the immune system, targeting bottlenecks that tumors use to subvert the immune system in order to develop precision immunotherapies for molecularly defined patient populations. This newly disclosed program adds a unique way to use B cells to drive anti-tumor responses."

Clinical • Oncology • Solid Tumor